Cart summary

You have no items in your shopping cart.

Azelastine hydrochloride

SKU: orb1223994

Description

Azelastine HCl is a potent, second-generation, selective, histamine antagonist.(In Vitro):Azelastine hydrochloride can significantly inhibit HNEpC proliferation, and therefore, be helpful in against airway remodeling.(In Vivo):Azelastine hydrochloride (4 mg/kg; p.o.; daily; for 8 weeks) significantly reduces blood glucose, HbA1c and serum alkaline phosphatase (ALP), osteocalcin and downregulates apolipoprotein B in diabetic hyperlipidemic rats model.Azelastine hydrochloride (4 mg/kg; p.o.; daily; for 8 weeks) improves the lipid profile (LDL-c decrease and HDL-c increase) in diabetic hyperlipidemic rats model.Azelastine hydrochloride (4 mg/kg; p.o.; daily; for 8 weeks) attenuates calcium deposition and aortic calcification in diabetic hyperlipidemic rats model.

Images & Validation

Key Properties

CAS Number79307-93-0
MW418.36
Purity>98% (HPLC)
FormulaC22H24ClN3O·HCl
SMILESCN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl
TargetHistamine Receptor
SolubilityEthanol: 84 mg/mL (200.78 mM); Water: 35 mg/mL (83.66 mM); DMSO: 84 mg/mL (200.78 mM)

Bioactivity

In Vivo
Azelastine hydrochloride (4 mg/kg; p.o. ; daily; for 8 weeks) significantly reduces blood glucose, HbA1c and serum alkaline phosphatase (ALP), osteocalcin and downregulates apolipoprotein B in diabetic hyperlipidemic rats model. Azelastine hydrochloride (4 mg/kg; p.o. ; daily; for 8 weeks) improves the lipid profile (LDL-c decrease and HDL-c increase) in diabetic hyperlipidemic rats model. Azelastine hydrochloride (4 mg/kg; p.o. ; daily; for 8 weeks) attenuates calcium deposition and aortic calcification in diabetic hyperlipidemic rats model. Animal model: Male albino Wistar rats (150-170 g), diabetic hyperlipidemic rats model. Dosage: 4 mg/kg. Administration: Oral administration, daily, for 8 weeks. Result: Ameliorated aortic calcification and increased apolipoprotein A expression along with a decline in apolipoprotein B.
In Vitro
Azelastine hydrochloride can significantly inhibit HNEpC proliferation, and therefore, be helpful in against airway remodeling. Cell Proliferation Assay Cell line: Human nasal epithelial cells (HNEpC). Concentration: 100 μM, 400 μM. Incubation time: 21 days. Result: Inhibited HNEpC growth. Western blot analysis. Cell line: Human nasal epithelial cells (HNEpC). Concentration: 100 μM. Incubation time: 7 days. Result: Significantly up-regulated the H1R, M1R and M3R levels.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Azelastine HCl | Astelin | Optivar | Allergodil | Rhinolast | Azeptin

Similar Products

  • Azelastine hydrochloride [orb1310831]

    >99.99% (May vary between batches)

    79307-93-0

    418.36

    C22H24ClN3O·HCl

    1 ml x 10 mM (in DMSO), 50 mg
  • (R)-Azelastine hydrochloride [orb1738999]

    99.99% (May vary between batches)

    153408-28-7

    418.36

    C22H25Cl2N3O

    50 mg, 100 mg, 25 mg
  • (S)-Azelastine hydrochloride [orb1705236]

    153408-27-6

    418.36

    C22H25Cl2N3O

    1 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Azelastine hydrochloride (orb1223994)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%